Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
Top New Articles on HCV
All HCV Articles by Topic ( A to Z )
HCV Basics
HIV-HCV Coinfection
FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
Treatment Guidelines for HCV
Experimental Treatments for HCV
Recent Research Conference Reports
Tests for HCV
Liver-related Complications
Drug-related Adverse Events
Doctor Is In 'Q and A' for HCV
Library of CME Programs
E-mail Update - Sign Up
About Us - Contact Us
_______________
Epidemiology
( Latinos / Caucasians)
Link to
African Americans
Assessment of Liver Fibrosis in African Americans and
Caucasians
with Hepatitis C
10/10/06
Gene Response to Interferon Therapy for Hepatitis C Differs by
Race
- 8/22/06
Hispanics
with Chronic Hepatitis C May Develop More
Advanced Fibrosis
- 7/18/06
Ethnic Differences in the Presentation of Chronic Hepatitis C
- 3/17/06
Roche Will Expand Study Comparing Hepatitis C Response Rates in
Latinos and Non-Latino Caucasians
Treated with Pegasys Plus Copegus
- 11/04/05
High prevalence of Dual or Triple Infection of Hepatitis B, C and Delta Viruses among Patients with Chronic Liver Disease in Mongolia
- 10/31/05
Chronic Hepatitis C in
Latinos
- 10/12/05
T-cell Response to Genotype and
Ethnicity
during Therapy for Chronic Hepatitis C
- 6/13/05
Hepatitis C Virus and Metabolic Disturbances
- 5/27/05
Clustering of Poor Prognostic Characteristics Such as
Male Gender, Black Race
and Injection Drug Use May Explain Lower Sustained Response Rates SVR in Heavier Patients
- 4/15/05
Slide Presentations Offer Expert Opinion on Current Approaches to Treatment of Chronic HCV in Various Populations
- 1/12/05
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US